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Abstract
Background: Influenza epidemics have a substantial impact on human health, by increasing the mortality from pneumonia
and influenza, respiratory and circulatory diseases, and all causes. This paper provides estimates of excess mortality rates
associated with influenza virus circulation for 7 causes of death and 8 age groups in Portugal during the period of 1980–
2004.
Methodology/Principal Findings: We compiled monthly mortality time series data by age for all-cause mortality,
cerebrovascular diseases, ischemic heart diseases, diseases of the respiratory system, chronic respiratory diseases,
pneumonia and influenza. We also used a control outcome, deaths from injuries. Age- and cause-specific baseline mortality
was modelled by the ARIMA approach; excess deaths attributable to influenza were calculated by subtracting expected
deaths from observed deaths during influenza epidemic periods. Influenza was associated with a seasonal average of 24.7
all-cause excess deaths per 100,000 inhabitants, approximately 90% of which were among seniors over 65 yrs. Excess
mortality was 3–6 fold higher during seasons dominated by the A(H3N2) subtype than seasons dominated by A(H1N1)/B.
High excess mortality impact was also seen in children under the age of four years. Seasonal excess mortality rates from all
the studied causes of death were highly correlated with each other (Pearson correlation range, 0.65 to 0.95, P,0.001) and
with seasonal rates of influenza-like-illness (ILI) among seniors over 65 years (Pearson correlation rho.0.64, P,0.05). By
contrast, there was no correlation with excess mortality from injuries.
Conclusions/Significance: Our excess mortality approach is specific to influenza virus activity and produces influenza-
related mortality rates for Portugal that are similar to those published for other countries. Our results indicate that all-cause
excess mortality is a robust indicator of influenza burden in Portugal, and could be used to monitor the impact of influenza
epidemics in this country. Additional studies are warranted to confirm these findings in other settings.
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Introduction
Influenza is an acute respiratory viral infection which typically
occurs in the winter months in temperate areas. Seasonal influenza
epidemics have a substantial mortality and morbidity impact on
human health globally [1,2,3]. The exact burden of influenza is
difficult to quantify because laboratory tests are rarely conducted
on a routine basis. Further, influenza can trigger secondary
bacterial infections or exacerbate existing chronic conditions,
which can lead to hospitalization or death, even after the primary
viral infection has been cleared. As a result, influenza disease
burden studies rely on the application of statistical time series
methods to broadly-defined disease outcomes, such as mortality
and hospitalization from pneumonia and influenza (P&I) or
respiratory and cardiovascular diseases (R&C), or all-cause mor-
tality (ACM) [4,5,6,7,8].
Various methodological approaches have been used to
determine the health burden of seasonal influenza. In general,
excess mortality attributable to influenza is based on the difference
between the observed mortality rate during an influenza epidemic
period and a predicted baseline describing expected seasonal
mortality fluctuations in the absence of influenza [9,10]. Excess
morbidity is calculated in much the same way. Statistical models,
such as Poisson regression [11], multiple linear regression [12],
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e20661cyclical regression [13], and autoregressive integrated moving
average (ARIMA) [1], have been used to estimate excess mortality
and take into account factors that are independent of influenza
activity, such as seasonal variations and temporal trends in
baseline mortality.
A substantial body of evidence suggests that age is one of the
most important risk factors when considering the health impact of
influenza. Children under 5 years and adults 65 years and older
are considered to be at an increased level of risk for influenza-
related complications during inter-pandemic periods [8,14].
Several studies have explored the influenza-associated rates of
hospitalization and death among seniors in the US, Canada, and
Europe, as well as in a few high-income tropical settings
[11,15,16,17]. Very little information, however, is available for
Southern Europe, with only one mortality study set in Italy [18].
In particular, no estimates for Portugal exist in the English-
speaking literature. In this study, we provide estimates of excess
mortality associated with influenza virus activity in Portugal by
death category, age group, and circulating subtypes for 1980–2004
and compare our estimates with those from other locations.
Materials and Methods
Mortality and population data
Mortality data available for 1980–2004 were obtained from the
Portuguese National Mortality Database of the Instituto Nacional
de Estatı ´stica (National Statistics Institute in Portugal). The 9
th
revision of the WHO International Classification of Diseases
(ICD-9) was used until 2001, and the 10
th revision (ICD-10) was
used thereafter. We compiled monthly mortality time series data
according to age group (0–4, 5–54, 55–64, 65–69, 70–74, 75–79,
80–84 and $85 years) for all-cause mortality (ACM) and the
following primary causes of death: cerebrovascular disease (ICD-9:
430–438, ICD-10: I60.0–I69.8); ischemic heart disease (ICD-9:
410–414, ICD-10: I20.0–I25.9); diseases of the respiratory system
(ICD-9: 460–519, ICD-10: J00–J99); chronic respiratory diseases,
including bronchitis, asthma, and emphysema (ICD-9: 490–495
and ICD-10: J41–J47); pneumonia (ICD-9: 480–486, ICD-10:
J12.0–J18.9) and influenza (ICD-9: 487, ICD-10: J10.0–J11.8).
To evaluate the specificity of our approach, we also studied
deaths from intentional and non-intentional injuries (ICD-9, E-
codes and ICD-10, codes V-Y), which we considered as a
‘‘control’’ outcome with no direct causal association with influenza
activity.
Age-specific annual population estimates from 1980 to 2004
were downloaded from the Instituto Nacional de Estatı ´stica
website (http://www.ine.pt) [19] and used to derive monthly death
rates by disease outcome and age group. Additionally, all monthly
time series were standardized to a fixed number of days in the
month (30.4 days). In order to cover influenza epidemic seasons,
which can occur from October to May in Portugal, we defined 24
respiratory seasons starting in July of the first available year (1980)
and ending in June of the last available year (2004).
Influenza-like illness and virological surveillance data
An integrated clinical, epidemiological and virological influenza
surveillance system was established in Portugal in the winter of
1990–1991. Data on influenza-like illnesses (ILI), as defined in
primary care [20], were collected by a network of general Sentinel
practitioners (GPs; Me ´dicos-Sentinela) which covers approximate-
ly 2.3% of the Portuguese population. Weekly ILI incidence rates
were calculated based on these data. A subset of 25–35% of GPs
also provided respiratory specimens to conduct virological
surveillance. Respiratory specimens were centralized at the Centro
Nacional da Gripe of Instituto Nacional de Sau ´de Dr. Ricardo
Jorge (National Influenza Centre of National Health Institute Dr.
Ricardo Jorge) in Lisbon and tested for influenza A/H3N2, A/
H1N1 and B subtypes by PCR or culture. Influenza subtype
dominance each season was defined as the subtype that was
isolated in at least 51% of the influenza-positive ILI cases.
Definition of influenza epidemic periods
For most of the study period, 1980–81 to 2001–02, influenza
epidemic periods were identified based on monthly deaths coded
specifically as influenza, which is considered a specific indicator of
the timing of epidemics [6,18]. We used a Serfling cyclical
regression model [13] to predict baseline mortality in the absence
of influenza activity and define epidemic periods, as in [6,18]. The
model included time trends and seasonal terms and was fitted to
data after exclusion of winter months (December to April),
following:
yt~az
X3
i~1 aitizb1 sin 2pt=12 ðÞ zb2 cos 2pt=12 ðÞ zet
where yt is the number of influenza-specific deaths in month t; t is
a running index for time; a is the intercept; a1,a 2 and a3 are
coefficients for time trends in baseline mortality; b1 and b2 are
seasonality coefficients; and et represents normally distributed
errors.
Influenza epidemic periods were defined as the set of consecutive
months from November to April where the observed number of
influenza-specific deaths exceeds the 95% upper confidence limit of
the model baseline [6,18].
Following the transition from the 9
th to the 10
th revision of ICD
in 2002, influenza-specific mortality decreased dramatically, and
influenza epidemic periods could not be defined based on these
data alone. For the remaining seasons 2002–2004, epidemic
periods were defined by the Portuguese Influenza Surveillance
System (ISS) as the weeks where ILI incidence rate exceeded the
upper 95% confidence limit of the ILI baseline and where
influenza virus circulation was confirmed by laboratory tests, as in
[21]. Since mortality data were available on a monthly basis, we
considered a given month to be epidemic if at least one week
during that month was considered epidemic in the ISS. We also
checked the consistency of using influenza-specific deaths and ILI
incidence to define epidemic periods, based on the subset of years
where both types of data were available (1991–2002).
Estimation of influenza-associated excess deaths
A modified Serfling cyclical regression model was applied to
each age group and death outcome (pneumonia, chronic
respiratory diseases, all respiratory diseases, cerebrovascular
diseases, ischemic heart diseases) to estimate baseline deaths in
the absence of influenza activity. Influenza-associated deaths were
defined as those deaths occurring in excess of the baseline
predicted by a seasonal model during influenza epidemic periods
[13], as explained briefly below and detailed in Text S1.
We used the Autoregressive Integrated Moving Average
(ARIMA) framework to fit baseline models of the expected level
of mortality in the absence of influenza virus activity and handle
auto-correlation, similarly to previous efforts [22,23][9]. The
assumption of independence of observations is rarely fulfilled by
the typical cyclical linear regression approach [13].
We first replaced observed values occurring during previously-
defined influenza epidemic periods by missing values, for each age
group and outcome. Since ARIMA models cannot handle missing
values, we replaced the missing values by the predicted values of a
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PLoS ONE | www.plosone.org 2 June 2011 | Volume 6 | Issue 6 | e20661cyclical linear regression model (similar to [22,24]). The cyclical
regression model was fitted to the log-death rates, including
harmonics and time trends up to the 5
th degree polynomial.
In the next step, we fitted a Seasonal-ARIMA (SARIMA) model
to the augmented time series. The terms included in the SARIMA
model were selected by applying an automatic algorithm using the
minimal Akaike Information Criterion (AIC) [25]. The selected
SARIMA model was then used to predict baseline mortality for
each age group and mortality outcome.
In order to evaluate model adequacy, we computed the Box-
Ljung test for autocorrelation and the Kolmogorov-Smirnov test
for normality of model residuals outside of epidemic periods.
Within each epidemic period, the months with excess influenza-
associated deaths were defined as those where the observed rates
were above the 95% upper confidence limit of the baseline.
Influenza-associated excess death rates for each of these months
were estimated by taking the difference between observed and
baseline rates. Finally, the cumulative number of influenza excess
deaths by season was calculated as the sum of monthly influenza-
associated excess deaths, after adjusting these rates for population
size and true month length. As a sensitivity analysis, we repeated
our estimations of excess mortality using a simple cyclical
regression model, as in [6,18].
Confidence intervals for seasonal and age-standardized excess
death estimates were obtained by taking into account the
uncertainty of the baseline, assuming that the sum of monthly
excess deaths during epidemic periods followed a Log-normal
distribution, and using the Fenton-Wilkinson method [27] (see
Text S1).
Results are presented as crude and age-standardized rates using
the 2000 world population as a reference [26]. We also present the
proportion of deaths attributable to influenza among all deaths
occurring from October to May (influenza season), averaged
across all influenza seasons (IS%).
The association between seasonal age-standardized excess
mortality rates from various causes, and between excess mortality
and seasonal ILI attack rates (cumulative ILI rates during week 40
to week 20 of the following calendar year) was evaluated using the
Pearson correlation coefficient.
All results were computed in the R Environment for Statistical
Computing [28].
Results
Overall burden of influenza
Portugal experiences highly seasonal influenza activity concen-
trated in winter months, with peaks in influenza-specific mortality
occurring between December and March. As in other developed
countries, the impact of influenza epidemics varies greatly between
years, as illustrated by important year-to-year variation in the size of
pneumonia and influenza and all-cause mortality peaks (Figure 1).
During the study period, 1980–2004, the seasonal average
number of all cause excess deaths associated with influenza
epidemics was 2,475 in Portugal (range.=0 to 8514), 90% of
which occurred in people aged $65 years, representing a crude
excess all-cause death rate of 26 per 100,000. The corresponding
average age-standardized rate was 13 per 100,000 inhabitants,
representing an average of 3% of total deaths occurring between
October and May (range 0 to 9.2%, Table 1). In seniors 65 years
and over, the average age-standardized excess death rate during
these months was 156 per 100,000 inhabitants, representing 4% of
all October-May deaths in this age group (range 0 to 11.9%).
For cerebrovascular and ischemic heart disease outcomes, the
average age-standardized death rate were 2.9 and 0.7 per 100,000,
respectively, representing averages of 3.2% and 2% of the age-
standardized mortality rate for those causes during the influenza
season (Table 2). The age-standardized mortality rates was 3.1/
100,000 for respiratory diseases, 1.5/100,000 for pneumonia and
Figure 1. All age mortality rates for all causes, diseases of the respiratory system and pneumonia and influenza from 1980/81 to
2003/2004 in Portugal. Grey highlights represent influenza epidemic periods.
doi:10.1371/journal.pone.0020661.g001
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(CRD). Influenza was responsible for 9.9%, 9.3% and 6.9% on
average of all deaths from P&I causes, respiratory diseases, and
chronic respiratory diseases, respectively. Similar results were
observed for the elderly ($65 yrs) (Table 2). We estimate than on
average 662 respiratory deaths are attributable to influenza every
season in Portugal, of which 44% are coded as P&I.
Age-specific estimates
The distribution of age-specific all-cause excess mortality rates
followed a J-shape, with highest rates in seniors over 65 yrs, and the
0–4 age group experiencing higher excess mortality rates than
individuals aged 5–54 years (Table 2 and Figure 2). In children under
5 yrs, no excess deaths could be attributed to influenza in chronic
respiratory diseases, ischemic heart diseases or cerebrovascular
diseases. There were very few deaths coded as such in this age group.
Excess mortality rates increased exponentially with age for age
groups over 55 years. This pattern was also observed for excess
mortality from P&I and CRD but not for the other causes of death
studied. Interestingly, the J-shape almost disappeared when exploring
the age-specific proportion of October-May deaths attributable to
influenza, which instead demonstrated a near linear association with
age (Figure 2). This suggests that measuring the proportion of excess
deaths due to influenza is a good way to standardize burden estimates
across age groups (and possibly across time and geography).
Burden of influenza according to season and dominant
sub-type
Of the 24 influenza seasons studied, 14 were dominated by the
more severe A/H3N2 subtype (Table 1). Average excess mortality
rates were 3.3–6.1 higher for seasons dominated by A(H3) viruses
compared to seasons dominated by influenza B or A(H1),
depending on the outcome studied (Table 2). Seasons associated
with the highest excess mortality rates (eg, 1998–99 and 1980–81)
had an especially high disease burden in people aged $65 years.
Five of the 24 seasons were associated with no excess death in any
of the studied causes.
Comparison of influenza-related excess mortality and
morbidity
We compared seasonal excess mortality patterns in seniors over
65 years (who account for the majority of influenza-related
deaths) with morbidity patterns in ILI consultation rates in the
same age group. The correlation between age-standardized
influenza-associated mortality rates for the studied causes and
seasonal ILI consultation rates ranged between 0.64 and 0.83
(P,0.05; Table S3). These results show that high ILI seasons
were associated high excess mortality seasons among seniors. We
also conducted a sensitivity analysis of the ILI data by estimating
excess ILI rates occurring during epidemic periods, rather than
cumulative ILI rates during Oct-May, and found very similar
correlation patterns with excess mortality (Figure S1 and Tables
S1 and S2). In Figure 3 we present the results for Pneumonia and
Influenza.
Influenza epidemic periods validation and model
diagnostics
We used two approaches to define epidemic periods; one was
based on influenza-specific deaths and the other on the Portuguese
Influenza Surveillance System, combining ILI and influenza
Table 2. Average rates of excess mortality associated with influenza epidemics and proportion of deaths attributable to influenza
by disease outcome, age group, and dominant viral subtype, Portugal 1980–2004.
All causes
Cerebrovascular
diseases
Ischemic
heart disease
Diseases of the
respiratory system
Pneumonia and
Influenza
Chronic respiratory
diseases
Rate IS% Rate IS% Rate IS% Rate IS% Rate IS% Rate IS%
All individuals* 12.97 3.0 2.88 3.2 0.69 2.0 3.14 9.3 1.45 9.9 0.77 6.9
Individuals 65+* 155.75 4.0 38.48 3.5 8.19 2.3 35.69 10.1 16.86 11.6 9.09 10.0
Age-groups
0–4 2.57 1.3 *** *** *** *** 0.40 2.5 0.7 6.0 *** ***
5–54 0.97 0.8 0.08 1.2 0.07 1.1 0.4 8.1 0.2 7.2 0.1 4.1
55–64 14.2 2.0 1.02 1.1 0.93 1.2 4.0 9.8 1.0 7.7 1.0 5.3
65–69 34.96 2.6 4.51 1.7 3.49 2.2 11.5 11.8 3.5 12.0 5.0 10.7
70–74 78.8 3.4 19.19 3.3 3.5 1.3 18.9 10.0 6.2 10.3 5.6 6.5
75–79 170.7 4.2 41.85 3.5 10.4 2.5 37.2 10.4 14.8 11.3 10.7 7.3
80–84 332.3 4.6 96.50 4.3 17.4 2.8 74.7 11.2 40.9 14.3 14.4 6.3
85+ 825.8 5.5 207.10 4.8 33.5 3.2 174.2 11.8 103.5 14.1 33.6 8.9
Dominant subtype of virus*
A(H3) 18.0 4.2 3.8 4.3 1.0 2.8 4.5 13.4 2.1 13.9 1.1 9.9
B or A(H1) 4.1 0.9 1.2 1.3 0.1 0.4 0.7 2.1 0.4 2.9 0.2 1.7
Ratio=A(H3)/B or A(H1) 4.4 4.5 3.1 3.4 6.8 7.5 6.8 6.5 5.5 4.8 5.0 5.7
p** 0.001 0.001 0.015 0.004 0.001 0.001 ,0.001 ,0.001 ,0.001 ,0.001 0.001 ,0.001
*age-standardized rates; % IS: proportion of winter death attributable to influenza; calculated as the ratio of excess deaths to death occurring from October to May , by
age group, mortality outcome, and season;
**Mann-Whitney test for comparison of excess mortality during A(H3) and A(H1) or B seasons;
***data not presented due to small death counts.
Rates are per 100,000 population.
doi:10.1371/journal.pone.0020661.t002
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consistent in the period when both datasets overlapped, 1991–
2002 (Table 1). There was a lag of 0 to 1 month between epidemic
periods defined by the Surveillance System and influenza-specific
mortality, except for the mild 1994–1995 season, where epidemic
periods did not match.
Model fit was relatively good as there was no auto-correlation in
the residuals of the SARIMA models in 46 out of the 48 models;
Figure 2. Age-specific influenza excess mortality burden. Average rates (per 100.000 persons) and proportion of winter mortality associated
with influenza epidemics from 1980–1981 to 2003–2004 by age group: A. All causes, B. Cerebrovascular diseases, C. Ischemic heart diseases, D. All
respiratory diseases, E. Pneumonia and Influenza (P&I), F. Chronic respiratory diseases. (* data not presented due to low annual number of deaths).
The proportion of winter mortality attributable to influenza was calculated as the ratio of seasonal excess mortality to mortality occurring during Oct–
Mar, for each disease outcome and age group.
doi:10.1371/journal.pone.0020661.g002
Figure 3. Association between seasonal rates of excess pneumonia and influenza (P&I) and seasonal rates of influenza like illnesses
in the elderly population over 65 yrs.
doi:10.1371/journal.pone.0020661.g003
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Table S3 and figures S2–S9 for observed rates and modeled
baselines.) Seasonal excess mortality estimates were generally
consistent across the various causes of death studied (correlation
range, 0.65 to 0.95, P,0.05; Table S4). In particular the
correlation between all-causes excess deaths and excess P&I
deaths was very high at 0.95 (P,0.001). Finally, we compared
estimates derived from the SARIMA approach with those derived
from a traditional Serfling seasonal linear regression and found
very consistent results, with correlations ranging between 0.5 and
0.99 (P,0.05) depending on the mortality outcome and age group
considered.
Specificity analysis
Next, we applied the same excess mortality approach to deaths
from injuries, to check that the method did not spuriously attribute
deaths to influenza for unrelated outcomes. The seasonality of
injuries was out-of-phase with that of influenza and displayed
summer peaks, especially pronounced in 5–65 yrs. On average for
the 24 seasons under study, our excess mortality approach
attributed only 0.66% of all injury deaths to influenza (Table
S5), which is much lower than our estimates for other studied
causes of death (resp, 3–9%).
In addition, seasonal age-standardized excess mortality rates
from injuries were not correlated with excess rates from causes that
are traditionally associated with influenza (P.0.05 for correlation
with excess deaths from P&I, chronic respiratory diseases; all
respiratory diseases; cardiovascular disease; ischemic heart disease;
all-causes; Table S4). Finally, there was no correlation between
seasonal excess deaths from injuries and seasonal ILI attack rates
in seniors.
Discussion
This is the first study to provide estimates of influenza seasonal
mortality burden in the Portuguese population, an important step
in designing rational national public health measures and in
comparing rates with other countries. On average, 2,475 excess
all-cause deaths were attributable to influenza in Portugal each
winter during 1980–2004 (range=0 to 8514), corresponding to a
seasonal excess mortality rate of 24.7 per 100,000, and a 2000
world population age-adjusted rate of 13 per 100,000.
Our estimates of influenza-related excess mortality rate are in
accordance with previous studies. In the US, Thompson et al.
estimated an average excess mortality rate of 19.6 per 100,000
inhabitants [8], while Schanzer et al. [16] calculated that influenza
was responsible for an excess mortality rate of 13.0 per 100,000 in
Canada. In Europe, excess mortality rates varied between 16.0 per
100,000 in Germany [29] and 26.0 per 100,000 in the Czech
Republic [7].
Despite the fact that P&I and all-cause excess mortality are
considered reliable indicators of influenza mortality impact [8,30],
here we used a more comprehensive approach and evaluated the
impact of influenza epidemics on various causes of mortality in
Portugal [1]. Although excess mortality was observed for 7 causes
of death that are traditionally linked to influenza in this study, the
highest proportion of October-May deaths attributable to
influenza was observed for respiratory-related illnesses, with
proportions ranging between 6.9 and 9.9%. Since influenza can
precipitate other severe respiratory conditions, a higher influenza
attributable proportion is expected for respiratory diseases,
especially for pneumonia [31]. Similar results were obtained in
Canada [16] and the US [6,8], where pneumonia had the highest
estimated percentage (8%) of deaths attributable to influenza. By
contrast, all-cause mortality is a less specific outcome and we
estimate that only 3% of total October-May winter deaths in
Portugal can be attributable to influenza (4% in seniors over 65
years) This compares with estimates of 5% in the US [6] and 4.8%
in Italy [18]. We note there is substantial inter-annual variation in
this percentage in Portugal and in other countries [6,18], as the
burden of influenza epidemics varies considerably depending on
circulating strains and population immunity.
It is interesting to note that P&I excess deaths only captured on
average 11.2% of the total mortality burden of influenza in
Portugal. By contrast, excess cerebrovascular mortality was the
major contributor to total influenza-associated deaths (22.3%).
This is not entirely unexpected, as cerebrovascular disease is the
primary cause of death in Portugal [32]. For comparison,
estimates obtained in Canada show that the proportion of excess
deaths captured by P&I was 22.7% (8% for influenza and 14.7%
for pneumonia), while cerebrovascular disease only contributed to
6.5% of influenza-attributable deaths [16]. The major contributor
to influenza excess mortality in Canada was P&I and ischemic
heart disease, the latter outcome representing 22.9% of all
influenza-associated deaths. This finding is particularly relevant
because ischemic heart disease is the leading cause of death in
Canada [33]. Whether between-country differences in leading
causes of deaths and their association with influenza result from
differences in coding practices or health status remains unclear
and warrants further studies.
Overall, the selection of the most appropriate cause of death to
adequately measure the burden of influenza remains a point of
debate. On the one hand, the usage of influenza-specific deaths
grossly underestimates the actual impact of the influenza virus
[34]. For example, in this study, the ratio of all influenza-
attributable deaths to deaths coded specifically as influenza
reached 23, and the number of influenza-coded deaths declined
dramatically after 2002, in parallel with the transition of WHO
International Classification of Diseases from revision 9 to 10. On
the other hand, all-cause mortality lacks specificity and provides
less accurate estimates, especially for milder seasons [8]. As
reviewed in [1] and [35], the causal relationship between influenza
and cardiovascular disease is well established, so that mortality
from cardiovascular diseases should be more systematically
included in influenza mortality studies.
Seasons with highest estimates of excess deaths were character-
ized by a dominance of the A(H3) influenza viral subtype in
Portugal, a pattern that was consistent across all mortality
outcomes. A higher level of hospitalizations and deaths associated
with the A(H3) subtype is already well documented [6,8,29]. In
our study, influenza B seasons had generally very low impact. In
particular, the 5 seasons associated with no excess mortality were
dominated by influenza B or had high proportion of B viruses.
Influenza B is generally more prevalent in children and young
adults, who have lower risk of severe influenza-related outcomes
than seniors.
The age-standardized ratio of A(H3) vs. (A(H1) or B) excess
mortality was 4.8 and 3.6 for P&I and all causes in Portuguese
seniors, respectively. Similar results have been obtained in Italy
(ratios of 4.5 and 2.9, respectively) [18]. By contrast, the subtype
rate ratio for all-cause mortality was a much lower 2.8 in the US,
after taking into account population age differences [6]. These
differences could be explained by differences in the strength and
sampling protocols of laboratory virus surveillance systems in each
country and/or the definition of subtype-dominant seasons.
On average, 90% of influenza-associated excess deaths occurred
in the $65 years age group. Studies in the Netherlands [36] and
the US [8] estimated that 90–95% of influenza-related deaths
Influenza Excess Mortality in Portugal 1980–2004
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approach and time periods. In Portugal, the unadjusted rate of all-
cause excess mortality was 165 per 100,000 on average in people
$65 yrs. This value was 12–65% higher than estimates for Italy
[18], the Netherlands [37], the US [8], and Canada [16]. One
possible explanation for these differences could be the lower level
of influenza vaccine coverage in Portuguese seniors compared to
these countries. From 1998/99 to 2003/04, the influenza vaccine
coverage in the elderly increased from 31% to 47% in Portugal
[38]. While this progress is significant, these values were
considerably lower than coverage estimates in the other countries
over comparable time periods. For instance, seasonal influenza
vaccine coverage increased from 32% in 1993/94 to 61% in
2000/2001 in Italy [18] and from 31% in 1988/89 to 65% in
2000/2001 in the US [6]. We note that no decline in influenza
attributable excess mortality was observed in Italy and the US as
vaccination coverage increased [6,18], suggesting that vaccination
is not the only explanation for the higher excess mortality rates
observed among Portuguese seniors.
The average excess mortality rate for the children aged 0–4
years old in this study was 2.6/100,000, which is an order of
magnitude higher than findings from previous studies. A recent
study in the Netherlands did not find any excess mortality
associated with influenza in the younger groups during 1997–2003
[37]. Another study in the US showed that the average influenza-
associated excess death rates for children ,1 years and 1–4 years
of age were 0.3 and 0.2 per 100,000, respectively [8]. The US
study also estimated a much higher rate of excess mortality due to
respiratory syncytial virus (RSV) in these age groups, a finding that
is in line with many other studies that establish RSV as a
predominant respiratory virus in young children [39,40,41]. It is
possible that our estimates of influenza excess mortality for young
Portuguese children could be confounded by the co-circulation of
RSV. Unfortunately, no information on the circulation of RSV is
currently available for Portugal.
In this study, we found that excess mortality increased
exponentially with age beyond 50 years, while the proportion of
October-May deaths attributable to influenza increased more
linearly with age. This indicates that the increased risk of
influenza-related mortality with age is driven by the increase in
background risk of death and may even suggest that the etiological
fraction of influenza does not increase with age as much as other
potential causes.
There are several caveats worth noting in our study. First, we
relied on statistical models based on seasonal linear regression
and SARIMA to estimate the burden of influenza, which rely on
a number of assumptions. We have compared estimates from
our SARIMA approach with those from a traditional Serfling
seasonal linear regression [6,24] and found very consistent
results. In addition, we report a strong association between
seasonal rates of influenza like illness and excess mortality for
causes that are traditionally linked to influenza in the elderly
population. This result confirms the robustness of our estimates
of influenza-attributable excess death, since independent indi-
cators of influenza-related excess mortality and morbidity
coincide.
We have also checked the specificity of our approach by
estimating excess deaths attributable to influenza in injury
mortality time series. This specificity analysis revealed that the
proportion of injury deaths ‘‘attributable’’ to influenza was very
low, and that season-to-season variations in excess injuries were
not associated with ILI activity. This supports the conclusion that
our approach provides excess mortality estimates that are specific
to influenza.
In conclusion, the present study shows that influenza epidemics
in Portugal had in general the same profile as that described for
other temperate countries in the Northern Hemisphere. A few
issues could be further explored, in particular the potentially
higher mortality burden in extreme age groups (0–4 and $65),
compared to other countries. As in other countries, population
aging tends to increase the absolute burden of influenza, which has
important consequences for disease control and public health
strategies. Another important point to note is the fact that the
impact of influenza epidemics in Portugal was relatively well
captured in the all-cause mortality time series. This result supports
the use of this indicator for influenza surveillance purposes in
Portugal, in particular to give near real-time estimates of inter-
pandemic and pandemic influenza mortality impact [42,43,44].
We note that all-cause mortality is less dependent on diagnostic
and coding differences between countries, time periods, or during
unusual events like pandemics, as compared with cause-specific
indicators. Further studies in other settings are warranted to
confirm that all-cause mortality is an appropriate indicator to
compare the impact of influenza epidemics at a regional and
global scale [6,45,46].
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